Crosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells

Journal of Immunology

Volumn 185, Issue 6, 2010, Pages 3227-3238

  Garay, Jone ^a   D'Angelo, June A ^a   Park, YongKeun ^b   Summa, Christopher M ^c,d   Aiken, Martha L ^c   Morales, Eric ^c   Badizadegan, Kamran ^e   Fiebiger, Edda ^f   Dickinson, Bonny L ^a,c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d USA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD83 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXCHANGE PROTEIN ACTIVATED BY CAMP; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CELL SURFACE; CELL VIABILITY; CHEMOTAXIS; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOLOGICAL TOLERANCE; LYMPH NODE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DENDRITIC CELLS; ENZYME ACTIVATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOPHENOTYPING; MICE; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 78649853664     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903066     Document Type: Article

References (78)

1. Steinman, R. M., L. Bonifaz, S. Fujii, K. Liu, D. Bonnyay, S. Yamazaki, M. Pack, D. Hawiger, T. Iyoda, K. Inaba, and M. C. Nussenzweig. 2005. The innate functions of dendritic cells in peripheral lymphoid tissues. Adv. Exp. Med. Biol. 560: 83-97.
2. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
3. Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig, C. R. Mackay, S. Qin, and A. Lanzavecchia. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28: 2760-2769.
4. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779.
5. Steinman, R. M., D. Hawiger, K. Liu, L. Bonifaz, D. Bonnyay, K. Mahnke, T. Iyoda, J. Ravetch, M. Dhodapkar, K. Inaba, and M. Nussenzweig. 2003. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. N. Y. Acad. Sci. 987: 15-25.
6. Dhodapkar, M. V., R. M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193: 233-238.
7. Finke, L. H., K. Wentworth, B. Blumenstein, N. S. Rudolph, H. Levitsky, and A. Hoos. 2007. Lessons from randomized phase III studies with active cancer immunotherapies - outcomes from the 2006 meeting of the Cancer Vaccine Consortium (CVC). Vaccine 25(Suppl 2): B97-B109.
8. Finn, O. J. 2003. Cancer vaccines: between the idea and the reality. Nat. Rev. Immunol. 3: 630-641.
9. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4: 328-332.
10. Nestle, F. O., J. Banchereau, and D. Hart. 2001. Dendritic cells: On the move from bench to bedside. Nat. Med. 7: 761-765.
11. Thurner, B., I. Haendle, C. Röder, D. Dieckmann, P. Keikavoussi, H. Jonuleit, A. Bender, C. Maczek, D. Schreiner, P. von den Driesch, et al. 1999. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190: 1669-1678.
12. Rosenberg, S. A., J. C. Yang, and N. P. Restifo. 2004. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10: 909-915.
13. Li, K., K. J. Anderson, Q. Peng, A. Noble, B. Lu, A. P. Kelly, N. Wang, S. H. Sacks, and W. Zhou. 2008. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 112: 5084-5094.
14. Wilkin, F., X. Duhant, C. Bruyns, N. Suarez-Huerta, J. M. Boeynaems, and B. Robaye. 2001. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J. Immunol. 166: 7172-7177.
15. Goyarts, E., M. Matsui, T. Mammone, A. M. Bender, J. A. Wagner, D. Maes, and R. D. Granstein. 2008. Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp. Dermatol. 17: 188-196.
16. Maldonado-Arocho, F. J., and K. A. Bradley. 2009. Anthrax edema toxin induces maturation of dendritic cells and enhances chemotaxis towards macrophage inflammatory protein 3beta. Infect. Immun. 77: 2036-2042.
17. Delneste, Y., N. Herbault, B. Galea, G. Magistrelli, I. Bazin, J. Y. Bonnefoy, and P. Jeannin. 1999. Vasoactive intestinal peptide synergizes with TNF-alpha in inducing human dendritic cell maturation. J. Immunol. 163: 3071-3075.
18. Bagley, K. C., S. F. Abdelwahab, R. G. Tuskan, and G. K. Lewis. 2006. Cholera toxin indirectly activates human monocyte-derived dendritic cells in vitro through the production of soluble factors, including prostaglandin E(2) and nitric oxide. Clin. Vaccine Immunol. 13: 106-115.
19. Luft, T., M. Jefford, P. Luetjens, T. Toy, H. Hochrein, K. A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky. 2002. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100: 1362-1372.
20. de Rooij, J., F. J. Zwartkruis, M. H. Verheijen, R. H. Cool, S. M. Nijman, A. Wittinghofer, and J. L. Bos. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477.
21. Kawasaki, H., G. M. Springett, N. Mochizuki, S. Toki, M. Nakaya, M. Matsuda, D. E. Housman, and A. M. Graybiel. 1998. A family of cAMP-binding proteins that directly activate Rap1. Science 282: 2275-2279.
22. Cheng, X., Z. Ji, T. Tsalkova, and F. Mei. 2008. Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim. Biophys. Sin. (Shanghai) 40: 651-662.
23. Dao, K. K., K. Teigen, R. Kopperud, E. Hodneland, F. Schwede, A. E. Christensen, A. Martinez, and S. O. Døskeland. 2006. Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition. J. Biol. Chem. 281: 21500-21511.
24. Enserink, J. M., A. E. Christensen, J. de Rooij, M. van Triest, F. Schwede, H. G. Genieser, S. O. Døskeland, J. L. Blank, and J. L. Bos. 2002. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 4: 901-906.
25. Christensen, A. E., F. Selheim, J. de Rooij, S. Dremier, F. Schwede, K. K. Dao, A. Martinez, C. Maenhaut, J. L. Bos, H. G. Genieser, and S. O. Døskeland. 2003. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278: 35394-35402.
26. Geiss, G. K., R. E. Bumgarner, B. Birditt, T. Dahl, N. Dowidar, D. L. Dunaway, H. P. Fell, S. Ferree, R. D. George, T. Grogan, et al. 2008. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 26: 317-325.
27. Park, Y., G. Popescu, K. Badizadegan, R. R. Dasari, and M. S. Feld. 2006. Diffraction phase and fluorescence microscopy. Opt. Express 14: 8263-8268.
28. Popescu, G., Y. Park, N. Lue, C. Best-Popescu, L. Deflores, R. R. Dasari, M. S. Feld, and K. Badizadegan. 2008. Optical imaging of cell mass and growth dynamics. Am. J. Physiol. Cell Physiol. 295: C538-C544.
29. Barer, R. 1953. Determination of dry mass, thickness, solid and water concentration in living cells. Nature 172: 1097-1098.
30. Burgess, B. T., J. L. Myles, and R. B. Dickinson. 2000. Quantitative analysis of adhesion-mediated cell migration in three-dimensional gels of RGD-grafted collagen. Ann. Biomed. Eng. 28: 110-118.
31. Lorenowicz, M. J., J. van Gils, M. de Boer, P. L. Hordijk, and M. Fernandez-Borja. 2006. Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis. J. Leukoc. Biol. 80: 1542-1552.
32. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821-3835.
33. Foti, M., F. Granucci, D. Aggujaro, E. Liboi, W. Luini, S. Minardi, A. Mantovani, S. Sozzani, and P. Ricciardi-Castagnoli. 1999. Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site. Int. Immunol. 11: 979-986.
34. Randolph, G. J., G. Sanchez-Schmitz, and V. Angeli. 2005. Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin. Immunopathol. 26: 273-287.
35. Balabanian, K., B. Lagane, S. Infantino, K. Y. Chow, J. Harriague, B. Moepps, F. Arenzana-Seisdedos, M. Thelen, and F. Bachelerie. 2005. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280: 35760-35766.
36. Burns, J. M., B. C. Summers, Y. Wang, A. Melikian, R. Berahovich, Z. Miao, M. E. Penfold, M. J. Sunshine, D. R. Littman, C. J. Kuo, et al. 2006. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203: 2201-2213.
37. Gagliardi, M. C., and M. T. De Magistris. 2003. Maturation of human dendritic cells induced by the adjuvant cholera toxin: role of cAMP on chemokine receptor expression. Vaccine 21: 856-861.
38. MartIn-Fontecha, A., S. Sebastiani, U. E. Höpken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198: 615-621.
39. Sallusto, F., and A. Lanzavecchia. 2000. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177: 134-140.
40. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18: 593-620.
41. Caux, C., B. Vanbervliet, C. Massacrier, S. Ait-Yahia, C. Vaure, K. Chemin, M. C. Dieu-Nosjean And, and A. Vicari. 2002. Regulation of dendritic cell recruitment by chemokines. Transplantation 73(1, Suppl): S7-S11.
42. Caux, C., S. Ait-Yahia, K. Chemin, O. de Bouteiller, M. C. Dieu-Nosjean, B. Homey, C. Massacrier, B. Vanbervliet, A. Zlotnik, and A. Vicari. 2000. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22: 345-369.
43. Förster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Müller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23-33.
44. Infantino, S., B. Moepps, and M. Thelen. 2006. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J. Immunol. 176: 2197-2207.
45. Comerford, I., W. Litchfield, Y. Harata-Lee, R. J. Nibbs, and S. R. McColl. 2007. Regulation of chemotactic networks by 'atypical' receptors. Bioessays 29: 237-247.
46. Boldajipour, B., H. Mahabaleshwar, E. Kardash, M. Reichman-Fried, H. Blaser, S. Minina, D. Wilson, Q. Xu, and E. Raz. 2008. Control of chemokine-guided cell migration by ligand sequestration. Cell 132: 463-473.
47. Dambly-Chaudière, C., N. Cubedo, and A. Ghysen. 2007. Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev. Biol. 7: 23.
48. Knaut, H., and A. F. Schier. 2008. Clearing the path for germ cells. Cell 132: 337-339.
49. Perlin, J. R., and W. S. Talbot. 2007. Signals on the move: chemokine receptors and organogenesis in zebrafish. Sci. STKE 2007: pe45.
50. Valentin, G., P. Haas, and D. Gilmour. 2007. The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b. Curr. Biol. 17: 1026-1031.
51. Bai, Z., H. Hayasaka, M. Kobayashi, W. Li, Z. Guo, M. H. Jang, A. Kondo, B. I. Choi, Y. Iwakura, and M. Miyasaka. 2009. CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches. J. Immunol. 182: 1287-1295.
52. Mori, S., H. Nakano, K. Aritomi, C. R. Wang, M. D. Gunn, and T. Kakiuchi. 2001. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 193: 207-218.
53. Junt, T., H. Nakano, T. Dumrese, T. Kakiuchi, B. Odermatt, R. M. Zinkernagel, H. Hengartner, and B. Ludewig. 2002. Antiviral immune responses in the absence of organized lymphoid T cell zones in plt/plt mice. J. Immunol. 168: 6032-6040.
54. Ouwehand, K., S. J. Santegoets, D. P. Bruynzeel, R. J. Scheper, T. D. de Gruijl, and S. Gibbs. 2008. CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur. J. Immunol. 38: 3050-3059.
55. Okada, T., V. N. Ngo, E. H. Ekland, R. Förster, M. Lipp, D. R. Littman, and J. G. Cyster. 2002. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196: 65-75.
56. Blades, M. C., F. Ingegnoli, S. K. Wheller, A. Manzo, S. Wahid, G. S. Panayi, M. Perretti, and C. Pitzalis. 2002. Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice. Arthritis Rheum. 46: 824-836.
57. Blades, M. C., A. Manzo, F. Ingegnoli, P. R. Taylor, G. S. Panayi, H. Irjala, S. Jalkanen, D. O. Haskard, M. Perretti, and C. Pitzalis. 2002. Stromal cell-derived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCID mice. J. Immunol. 168: 4308-4317.
58. Bachmann, M. F., M. Kopf, and B. J. Marsland. 2006. Chemokines: more than just road signs. Nat. Rev. Immunol. 6: 159-164.
59. Stutte, S., T. Quast, N. Gerbitzki, T. Savinko, N. Novak, J. Reifenberger, B. Homey, W. Kolanus, H. Alenius, and I. Forster. Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells. Proc. Natl. Acad. Sci. USA 107: 8736-8741.
60. Kabashima, K., N. Shiraishi, K. Sugita, T. Mori, A. Onoue, M. Kobayashi, J. Sakabe, R. Yoshiki, H. Tamamura, N. Fujii, et al. 2007. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 171: 1249-1257.
61. Vanbervliet, B., N. Bendriss-Vermare, C. Massacrier, B. Homey, O. de Bouteiller, F. Brière, G. Trinchieri, and C. Caux. 2003. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198: 823-830.
62. Kabashima, K., K. Sugita, N. Shiraishi, H. Tamamura, N. Fujii, and Y. Tokura. 2007. CXCR4 engagement promotes dendritic cell survival and maturation. Biochem. Biophys. Res. Commun. 361: 1012-1016.
63. Howe, A. K. 2004. Regulation of actin-based cell migration by cAMP/PKA. Biochim. Biophys. Acta 1692: 159-174.
64. Howe, A. K., L. C. Baldor, and B. P. Hogan. 2005. Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. Proc. Natl. Acad. Sci. USA 102: 14320-14325.
65. Friedl, P., and B. Weigelin. 2008. Interstitial leukocyte migration and immune function. Nat. Immunol. 9: 960-969.
66. Wei, S. H., I. Parker, M. J. Miller, and M. D. Cahalan. 2003. A stochastic view of lymphocyte motility and trafficking within the lymph node. Immunol. Rev. 195: 136-159.
67. Miller, M. J., A. S. Hejazi, S. H. Wei, M. D. Cahalan, and I. Parker. 2004. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc. Natl. Acad. Sci. USA 101: 998-1003.
68. Bagley, K. C., S. F. Abdelwahab, R. G. Tuskan, T. R. Fouts, and G. K. Lewis. 2002. Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway. Infect. Immun. 70: 5533-5539.
69. Bagley, K. C., S. F. Abdelwahab, R. G. Tuskan, T. R. Fouts, and G. K. Lewis. 2002. Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J. Leukoc. Biol. 72: 962-969.
70. Anosova, N. G., S. Chabot, V. Shreedhar, J. A. Borawski, B. L. Dickinson, and M. R. Neutra. 2008. Cholera toxin, E. coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches. Mucosal Immunol. 1: 59-67.
71. Dertzbaugh, M. T., and C. O. Elson. 1990. Cholera toxin as a mucosal adjuvant. In Topics in Vaccine Adjuvant Research. D. R. Spriggs, and W. C. Koff, eds. CRC Press, Boca Raton, FL, p. 119-131.
72. Freytag, L. C., and J. D. Clements. 1999. Bacterial toxins as mucosal adjuvants. Curr. Top. Microbiol. Immunol. 236: 215-236.
73. Lycke, N., and J. Holmgren. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59: 301-308.
74. Dickinson, B. L., and J. D. Clements. 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63: 1617-1623.
75. Yarwood, S. J., G. Borland, W. A. Sands, and T. M. Palmer. 2008. Identification of CCAAT/enhancer-binding proteins as exchange protein activated by cAMP-activated transcription factors that mediate the induction of the SOCS-3 gene. J. Biol. Chem. 283: 6843-6853.
76. Borland, G., R. J. Bird, T. M. Palmer, and S. J. Yarwood. 2009. Activation of protein kinase C alpha by EPAC1 is required for the ERK- and C/EBPbeta-dependent induction of the SOCS-3 gene by cyclic AMP in COS1 cells. J. Biol. Chem. 284: 17391-17403.
77. Mazzoni, A., and D. M. Segal. 2004. Controlling the Toll road to dendritic cell polarization. J. Leukoc. Biol. 75: 721-730.
78. Xiao, B. G., Y. M. Huang, and H. Link. 2003. Dendritic cell vaccine design: strategies for eliciting peripheral tolerance as therapy of autoimmune diseases. BioDrugs 17: 103-111.